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Background: The choice of vascular access type is an important aspect of care for incident hemodialysis patients.
However, data from the Centers for Medicare & Medicaid Services (CMS) Medical Evidence Report (form CMS-2728)
identifying the first access for incident patients have not previously been validated. Medicare began requiring that
vascular access type be reported on claims in July 2010. We aimed to determine the agreement between the
reported vascular access at initiation from form CMS-2728 and from Medicare claims.
Methods: This retrospective study used a cohort of 9777 patients who initiated dialysis in the latter half of 2010
and were eligible for Medicare at the start of renal replacement therapy to compare the vascular access type
reported on form CMS-2728 with the type reported on Medicare outpatient dialysis claims for the same patients.
For each patient, the reported access from each data source was compiled; the percent agreement represented the
percent of patients for whom the access was the same. Multivariate logistic analysis was performed to identify
characteristics associated with the agreement of reported access.
Results: The two data sources agreed for 94% of patients, with a Kappa statistic of 0.83, indicating an excellent
level of agreement. Further, we found no evidence to suggest that agreement was associated with the patient
characteristics of age, sex, race, or primary cause of renal failure.
Conclusion: These results suggest that vascular access data as reported on form CMS-2728 are valid and reliable for
use in research studies.
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In hemodialysis patients, the choice of vascular access type
is of primary importance. It is generally accepted that
long-term use of catheters can cause vein stenosis [1,2],
and catheters are associated with adverse outcomes such
as infections and complications [3], compared with ar-
teriovenous fistulas (AVFs) and arteriovenous grafts
(AVGs). Additionally, rates of morbidity and mortality are
lower for patients who use an internal access (AVF or
AVG) [4-15], use of intravenous iron and/or erythropoi-
etin is often lower [16-18], and health care-related costs* Correspondence: csolid@usrds.org
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reproduction in any medium, provided the ormay be lower [19-22]. Clinical guidelines established by
the National Kidney Foundation cite these reasons in ad-
vocating use of AVFs whenever possible [23]. The Fistula
First campaign was developed to promote use of AVFs for
dialysis patients [24,25]. Placement rates for each type of
access have changed dramatically over the last 10 years
[26], with a decrease in catheter placement rates and an
increase in AVF placement rates.
In 2005, the Centers for Medicare & Medicaid Services
(CMS) revised the end-stage renal disease (ESRD) Medical
Evidence Report (form CMS-2728) to collect information
regarding the type of access used at the first outpatient
dialysis session for incident patients. While some studies
have used the vascular access data from form CMS-2728,
lack of validation of those data is cited as a limitation byd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Patient characteristics (n = 9777)
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ESRD, End-stage renal disease; SD, Standard deviation.
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to validate other data from form CMS-2728, resulting in
varying levels of validity and reliability [31-33].
Beginning in July 2010, outpatient dialysis facilities were
required to report the type of vascular access used for dialy-
sis on claims submitted to Medicare for payment. This rep-
resented the first time that vascular access was reported on
Medicare claims, and provided an opportunity to compare
the reported access on form CMS-2728 with the reported
access on Medicare claims. The purpose of this study was
to determine the agreement between the reported vascular
access at initiation from these two data sources.
Methods
Patients
To ensure the presence of Medicare outpatient dialysis
claims at hemodialysis initiation, only patients who were
eligible for Medicare before ESRD onset were considered
(for patients not Medicare eligible at initiation, Medicare
eligibility does not begin until the fourth month of dialy-
sis). Using the United States Renal Data System (USRDS)
database, we identified patients aged 67 years or older
at the time of initiation who began hemodialysis as their
first mode of renal replacement therapy in July through
December 2010, and who were Medicare eligible with
Medicare as their primary payer. Patients with missing
or invalid data from form CMS-2728 were excluded.
Eligible patients were also required to have at least one
valid Medicare outpatient dialysis claim within 14 days
after their ESRD incidence date. Patient characteristics
were obtained from the USRDS enrollment database.
Vascular access
The type of vascular access reported on form CMS-2728
was obtained from question 18d, “What access was used
on first outpatient dialysis?” Dialysis claims were identified
through the use of revenue center codes (0820 through
0829). To determine the vascular access reported on the
first Medicare outpatient dialysis claim after hemodialysis
initiation, Healthcare Common Procedure Coding System
(HCPCS) modifier codes were used; the modifiers V5, V6,
and V7 indicate catheter, AVG, and AVF, respectively.
Analysis
For each patient, the reported access from each data
source was compiled, and the percent agreement repre-
sented the percent of patients for whom the access was
the same (i.e., catheter, AVF, or AVG). The Kappa statistic
was calculated as another measure of agreement [34,35].
Multivariate logistic analysis was performed to identify
characteristics associated with the agreement of reported
access. The dichotomous response variable was whether
or not the reported access from the two data sources
agreed (1) or disagreed (0).Studies conducted under the auspices of the USRDS
are exempt from institutional review board approval.Results
Of the 13,662 incident hemodialysis patients aged 67 years
or older with Medicare coverage at initiation, 211 had an
invalid form CMS-2728 or unknown vascular access, and
another 3674 lacked an outpatient dialysis claim within
14 days of initiation, resulting in a final study cohort of
9777 patients. The average age was 77.2 years with a range
of 67 to 102 years (Table 1). About three-fourths of patients
were white, and another 18% were African American.
About 8% of patients identified as Hispanic. The most com-
mon primary causes of renal failure were diabetes (40%)
and hypertension (39%).
The distribution of vascular access type identified by
each data source and the number of instances of agree-
ment and disagreement appear in Table 2. One patient for
whom modifier codes indicated both a catheter and an
AVG on the first outpatient dialysis claim was included in
the catheter category. The two data sources produced very
similar distributions of vascular access use (78% catheter,
18% AVF, 4% AVG), and the two sources agreed on the re-
ported access type for 94% of patients, with a Kappa statis-
tic of 0.83 (P = 0.0066, 95% confidence interval 0.82-0.85).
Table 2 Agreement of reported access
Access reported on first outpatient dialysis claim
Catheter AVF AVG Total
Access reported on form CMS-2728 Catheter 7406 189 63 7658 (78.3)
AVF 200 1490 58 1748 (17.9)
AVG 34 29 308 371 (3.8)
Total 7640 (78.1) 1708 (17.5) 429 (4.4) 9777
Note: Values are n or n (%).
AVF, Arteriovenous fistula; AVG, Arteriovenous graft; CMS, Centers for Medicare & Medicaid Services.
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suggest that agreement was not associated with the pa-
tient characteristics of age, sex, race, Hispanic ethnicity,
or primary cause of renal failure. In fact, the P value for
the global test for the model was non-significant (likeli-
hood ratio P = 0.15), indicating no evidence that any in-
cluded variable was associated with the agreement in
reported vascular access.
Discussion
This study represents the first time that vascular access
data from form CMS-2728 have been compared with
the access type reported on Medicare outpatient claims
for the same patients. In general, we found excellent
agreement between the two data sources; 94% of the
time, the reported access was the same, and the Kappa
value of 0.83 is above the threshold of 0.75 typically as-
sociated with an indication of excellent agreement [36].
Additionally, from multivariate logistic regression, in-
stances of disagreement appeared to be independent of
the patient characteristics of age, sex, race, and primary
cause of renal failure. This is encouraging, because it
suggests that the validity is likely to be equally strong
across different patient populations. Disagreement was
more common when an AVF or AVG was reported than
when a catheter was reported. However, the use and
reporting of catheters far out-number the use andTable 3 Multivariate logistic regression on the agreement
of vascular access
Variable Estimated odds ratio P
Male sex Reference
Female sex 0.97 0.7296
Age 67–74 years Reference
Age 75–84 years 0.92 0.3720
Age≥ 85 years 1.09 0.5321
White race Reference
African American race 0.81 0.0520
Other race 0.80 0.2183
Non-Hispanic ethnicity Reference
Hispanic ethnicity 1.26 0.2067reporting of AVFs or of AVGs, and the distribution of
access type reported is in line with the overall distribu-
tion. For example, for the 258 cases in which outpatient
claims did not agree with AVF access reported on form
CMS-2728, 78% of the time the outpatient claims indi-
cated catheter use, which is exactly the percentage of
catheters reported overall, and what would be expected
if disagreement were random.
The limitations of this study should be noted. The
study population was limited to patients aged 67 years
or older, and the distribution of the access type used
(and reported) may not be representative of the entire
incident hemodialysis population. However, the analysis
of this population suggested that the validity was not asso-
ciated with age, and while the results are not generalizable
to the population aged younger than 67 years, there is
nothing to indicate that validity would differ significantly
in a younger population. Another limitation is that form
CMS-2728 may be filled out weeks or months after dialy-
sis initiation, with unknown consequences for the reliabil-
ity of the information on the form. However, for patients
in this study, the date of the physician’s signature on the
form occurred, on average, 20.4 days after the date that
regular dialysis began, and did not differ significantly (P =
0.36) for patients with access type agreement (20.5 days)
vs. those with lack of agreement (19.6 days) on the first
outpatient dialysis Medicare claim. Also, dialysis providers
are required to report only the vascular access used for
the last hemodialysis session of the month, and reporting
the access at each session is at the provider’s discretion.
Therefore, in some cases, the access reported on the dialy-
sis claim may not reflect the access used for the first out-
patient dialysis session. (In fact, agreement when form
CMS-2728 indicates a catheter is slightly worse when the
form also indicates presence of a maturing AVF or AVG,
possibly reflecting instances of a catheter being used at the
first session and an AVF or AVG having matured by the
end of the month and thus appearing on the outpatient
claim). However, this situation would only serve to in-
crease the difficulty of concordance with form CMS-
2728, making our findings all the more encouraging.
For researchers hoping to resolve cases in which the
data sources disagree, searching for claims involving
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may provide additional information regarding the type
or types of access present at initiation. Finally, this study
simply investigated concordance between two data
sources, not concordance with type of vascular access
actually present, which is ultimately unknown. Future
study is warranted, perhaps involving primary data col-
lection regarding the true vascular access used at each
dialysis session, to compare with access reported on
claims and on form CMS-2728.
Conclusions
The degree of agreement between form CMS-2728 and
outpatient dialysis claims reporting of the type of vascu-
lar access used at hemodialysis initiation should give re-
searchers confidence in using data from either source in
future studies.
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